
AI is about to change healthcare. These 42 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Himax Technologies, you need to believe its mix of automotive display ICs, AR components, and AI-vision products can offset pricing pressure and sector cyclicality. The latest Q2 2026 beat and positive Q3 outlook point to firmer short term profitability, but do not remove the key risk of demand volatility from trade tensions and customer inventory swings, which can still unsettle quarterly earnings and cash flows.
Against this backdrop, the recent decision to cut the 2025 cash dividend to 25.2 cents per ADS stands out. It sits in sharp contrast to the higher 37.0 cents per ADS paid for 2024 and, paired with Q2’s improved profitability, underlines how management is balancing shareholder returns with the need to preserve flexibility around capex, R&D, and potential macro or tariff driven shocks to revenue.
Yet beneath the improved quarter, investors should also be aware that rising tariffs and shifting customer orders could still...
Read the full narrative on Himax Technologies (it's free!)
Himax Technologies' narrative projects $1.5 billion revenue and $262.6 million earnings by 2029.
Uncover how Himax Technologies' forecasts yield a $23.70 fair value, a 78% upside to its current price.
Before this Q2 beat, the most cautious analysts were assuming revenue might still grow to about US$1.4 billion and earnings to roughly US$305 million, yet they stressed that concentration risk could cap returns, which shows just how far views can differ and why it is worth comparing these more pessimistic expectations with your own reading of the latest results.
Explore 6 other fair value estimates on Himax Technologies - why the stock might be worth less than half the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com